3 research outputs found
ΠΡΠ½ΠΎΠ²Π½ΡΠ΅ ΠΏΡΠΈΠ½ΡΠΈΠΏΡ Π²Π΅Π΄Π΅Π½ΠΈΡ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Π² ΠΏΠ΅ΡΠΈΠΎΠ΄ ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΠΈ COVID-19
In a COVID-19 pandemic, a neurologist needs to be able to assess the risks of virus infection in patients with individual neurological diseases. The review presents categories of risk groups from the Association of British Neurologists for neuromuscular diseases, multiple sclerosis and other autoimmune diseases of the central nervous system, stroke, epilepsy and Parkinsonβs disease. The risk of infection and the management of patients with neuromuscular diseases are analyzed in detail. The use of multiple sclerosis disease modifying drugs, the treatment of stroke patients are discussed. The data from the international guidelines for the management of patients with epilepsy and Parkinsonβs disease are presented.Π ΡΡΠ»ΠΎΠ²ΠΈΡΡ
ΠΏΠ°Π½Π΄Π΅ΠΌΠΈΠΈ COVID-19 Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³Ρ Π½Π΅ΠΎΠ±Ρ
ΠΎΠ΄ΠΈΠΌΠΎ ΡΠΌΠ΅ΡΡ ΠΎΡΠ΅Π½ΠΈΡΡ ΡΠΈΡΠΊΠΈ Π·Π°ΡΠ°ΠΆΠ΅Π½ΠΈΡ Π²ΠΈΡΡΡΠΎΠΌ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΎΡΠ΄Π΅Π»ΡΠ½ΡΠΌΠΈ Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΌΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ. Π ΠΎΠ±Π·ΠΎΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ ΠΊΠ°ΡΠ΅Π³ΠΎΡΠΈΠΈ Π³ΡΡΠΏΠΏ ΡΠΈΡΠΊΠ° ΠΎΡ ΠΡΡΠΎΡΠΈΠ°ΡΠΈΠΈ Π±ΡΠΈΡΠ°Π½ΡΠΊΠΈΡ
Π½Π΅Π²ΡΠΎΠ»ΠΎΠ³ΠΎΠ² Π΄Π»Ρ Π½Π΅ΡΠ²Π½ΠΎ-ΠΌΡΡΠ΅ΡΠ½ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, ΡΠ°ΡΡΠ΅ΡΠ½Π½ΠΎΠ³ΠΎ ΡΠΊΠ»Π΅ΡΠΎΠ·Π° ΠΈ Π΄ΡΡΠ³ΠΈΡ
Π°ΡΡΠΎΠΈΠΌΠΌΡΠ½Π½ΡΡ
Π±ΠΎΠ»Π΅Π·Π½Π΅ΠΉ ΡΠ΅Π½ΡΡΠ°Π»ΡΠ½ΠΎΠΉ Π½Π΅ΡΠ²Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ, ΠΈΠ½ΡΡΠ»ΡΡΠ°, ΡΠΏΠΈΠ»Π΅ΠΏΡΠΈΠΈ ΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΠ°ΡΠΊΠΈΠ½ΡΠΎΠ½Π°. Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΡΠΈΡΠΊΠΈ Π·Π°ΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΈ ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π½Π΅ΡΠ²Π½ΠΎ-ΠΌΡΡΠ΅ΡΠ½ΡΠΌΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΠΌΠΈ. ΠΠ±ΡΡΠΆΠ΄Π΅Π½ΠΎ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠ², ΠΈΠ·ΠΌΠ΅Π½ΡΡΡΠΈΡ
ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΡΠ°ΡΡΠ΅ΡΠ½Π½ΠΎΠ³ΠΎ ΡΠΊΠ»Π΅ΡΠΎΠ·Π°, ΠΎΡΠΎΠ±Π΅Π½Π½ΠΎΡΡΠΈ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΠΈΠ½ΡΡΠ»ΡΡΠΎΠΌ ΠΏΡΠΈ COVID-19. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π΄Π°Π½Π½ΡΠ΅ ΠΈΠ· ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄Π°ΡΠΈΠΉ ΠΌΠ΅ΠΆΠ΄ΡΠ½Π°ΡΠΎΠ΄Π½ΡΡ
ΠΎΡΠ³Π°Π½ΠΈΠ·Π°ΡΠΈΠΉ ΠΏΠΎ Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ ΡΠΏΠΈΠ»Π΅ΠΏΡΠΈΠ΅ΠΉ ΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΡ ΠΠ°ΡΠΊΠΈΠ½ΡΠΎΠ½Π°
Basic principles for the management of neurological patients during the COVID-19 pandemic
In a COVID-19 pandemic, a neurologist needs to be able to assess the risks of virus infection in patients with individual neurological diseases. The review presents categories of risk groups from the Association of British Neurologists for neuromuscular diseases, multiple sclerosis and other autoimmune diseases of the central nervous system, stroke, epilepsy and Parkinson's disease. The risk of infection and the management of patients with neuromuscular diseases are analyzed in detail. The use of multiple sclerosis disease modifying drugs, the treatment of stroke patients are discussed. The data from the international guidelines for the management of patients with epilepsy and Parkinson's disease are presented. Β© 2020 ABV-Press Publishing House. All rights reserved